155 related articles for article (PubMed ID: 7600259)
1. Fibronectin expression in human mesangial cell cultures and its alterations by adriamycin.
Soose M; Wenzel S; Padur A; Oberst D; Stolte H
Cell Biol Toxicol; 1995 Feb; 11(1):51-63. PubMed ID: 7600259
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin turnover in human mesangial cell cultures as affected by adriamycin.
Soose M; Wenzel S; Stolte H
Cell Biol Toxicol; 1993; 9(2):149-63. PubMed ID: 8242431
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin metabolism by human mesangial cells: effects of collagens.
Cosio FG
Am J Physiol; 1993 Jan; 264(1 Pt 2):F106-19. PubMed ID: 8430822
[TBL] [Abstract][Full Text] [Related]
4. Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures.
Wenzel S; Stolte H; Soose M
J Pharmacol Exp Ther; 1996 Dec; 279(3):1520-6. PubMed ID: 8968378
[TBL] [Abstract][Full Text] [Related]
5. Rat mesangial cell-matrix interactions in culture.
Simonson MS; Culp LA; Dunn MJ
Exp Cell Res; 1989 Oct; 184(2):484-98. PubMed ID: 2553458
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin modulates interleukin 6 and fibronectin synthesis of human glomerular mesangial cells in culture.
Schieren G; Bürger A; Braunger M; Filsinger S; Hänsch GM
Exp Nephrol; 1996; 4(1):48-55. PubMed ID: 8788600
[TBL] [Abstract][Full Text] [Related]
7. Bacitracin inhibits fibronectin matrix assembly by mesangial cells in high glucose.
Weston BS; Wahab NA; Roberts T; Mason RM
Kidney Int; 2001 Nov; 60(5):1756-64. PubMed ID: 11703593
[TBL] [Abstract][Full Text] [Related]
8. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium.
Ayo SH; Radnik RA; Glass WF; Garoni JA; Rampt ER; Appling DR; Kreisberg JI
Am J Physiol; 1991 Feb; 260(2 Pt 2):F185-91. PubMed ID: 1996670
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypoxia on the extracellular matrix production of cultured rat mesangial cells.
Kim SB; Kang SA; Park JS; Lee JS; Hong CD
Nephron; 1996; 72(2):275-80. PubMed ID: 8684539
[TBL] [Abstract][Full Text] [Related]
10. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis.
Oh JH; Ha H; Yu MR; Lee HB
Kidney Int; 1998 Dec; 54(6):1872-8. PubMed ID: 9853252
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities.
Sugiura T; Imai E; Moriyama T; Horio M; Hori M
Nephron; 2000 May; 85(1):71-80. PubMed ID: 10773759
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibronectin by insulin-like growth factor-I in cultured rat thoracic aortic smooth muscle cells and glomerular mesangial cells.
Tamaroglio TA; Lo CS
Exp Cell Res; 1994 Dec; 215(2):338-46. PubMed ID: 7982472
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells.
Pugliese G; Pricci F; Pugliese F; Mene P; Lenti L; Andreani D; Galli G; Casini A; Bianchi S; Rotella CM
Diabetes; 1994 Mar; 43(3):478-90. PubMed ID: 8314022
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.
Ortíz A; Alonso J; Gómez-Chiarri M; Lerma JL; Seron D; Condom E; González E; Egido J
Clin Exp Immunol; 1995 Aug; 101(2):334-40. PubMed ID: 7648718
[TBL] [Abstract][Full Text] [Related]
16. The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing.
McKay NG; Khong TF; Haites NE; Power DA
Exp Mol Pathol; 1993 Dec; 59(3):211-24. PubMed ID: 8137903
[TBL] [Abstract][Full Text] [Related]
17. Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.
Barnes JL; Hastings RR; De la Garza MA
Am J Pathol; 1994 Sep; 145(3):585-97. PubMed ID: 8080041
[TBL] [Abstract][Full Text] [Related]
18. Altered renal fibronectin excretion in early adriamycin nephrosis of rats.
Soose M; Gwinner W; Grotkamp J; Hansemann W; Stolte H
J Pharmacol Exp Ther; 1991 Apr; 257(1):493-9. PubMed ID: 2020005
[TBL] [Abstract][Full Text] [Related]
19. Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins.
Roh DD; Kamanna VS; Kirschenbaum MA
Am J Nephrol; 1998; 18(4):344-50. PubMed ID: 9653842
[TBL] [Abstract][Full Text] [Related]
20. The 80-kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor-alpha (TNF-alpha) in cultured mesangial cells.
Lopez-Armada MJ; Gonzalez E; Gomez-Guerrero C; Egido J
Clin Exp Immunol; 1997 Feb; 107(2):398-403. PubMed ID: 9030881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
